Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-034233
Filing Date
2025-07-03
Accepted
2025-07-03 16:21:11
Documents
1
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751574063.html 4  
1 FORM 4 wk-form4_1751574063.xml 4 3992
  Complete submission text file 0001628280-25-034233.txt   5544
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 61 NORTH BEACON STREET, 4TH FLOOR BOSTON MA 02134
Business Address
Thoren Natasha Fay (Reporting) CIK: 0002070977 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 251105815